Global Partnership Discovery Series: Transforming Clinical development with AI
Global Partnership Discovery Series: Transforming Clinical Development with AI
An Exclusive Executive Reception During DIA 2026
Artificial Intelligence is rapidly becoming the next major force reshaping global clinical
development — from protocol design and medical writing to operational execution,
regulatory strategy, and investigator-initiated trials.
Join global pharmaceutical leaders, AI innovators, clinical development experts, academic researchers, healthcare executives, and investors for an exclusive evening forum during DIA 2026 in Philadelphia, hosted by GB-Partner in partnership with Deep Intelligent Pharma (DIP), a global leader in AI-powered clinical development.
This high-level executive gathering will spotlight how Agentic AI systems are transforming the future of drug development while creating new opportunities for international collaboration between the United States, Japan, and the global life
sciences ecosystem.
5:00 - 5:45pm: Registration check in, Happy Hour networking reception with music
performance
5:45 - 5:55 pm: Leaders' Opening Remarks
5:55 - 6:10 pm: Feature Presentation: AI & DCT: Decentralizing Clinical Trials in Japan
Speaker: Shinya Yamamoto (山本 晋也), PhD
Guest Professor at The University of Osaka School of Medicine; Visiting Professor at graduate School of Science, Technology and Innovation, Kobe University
Dr. Yamamoto will share how Japan’s innovation ecosystem is leveraging AI to accelerate
clinical development, translational medicine, and investigator-initiated clinical research.
6:10 - 6:25 pm: Feature Presentation: AI Applications at Osaka University Hospital
Speaker: Yu Moriguchi (森口 悠）M.D., Ph.D.
Specially Appointed lecturer, Future Medical Development Division & International Medical
Center, Osaka University Hospital
Dr. Moriguchi will discuss emerging trends and real-world applications of AI in clinical
innovation and future medical development.
6:25 - 7:15pm: Panel Discussion: Global Innovation, Strategic Partnerships, and the Future of AI-Enabled Drug Development
As development timelines, regulatory complexity, and clinical costs continue to rise globally, AI is increasingly recognized as one of the pharmaceutical industry’s most important next-generation technologies.
Moderators: Kevin He, Jiawei Tang
Panelists:
Dr. Shinya Yamamoto (山本 晋也), PhD
Yu Moriguchi (森口 悠）M.D., Ph.D.
Kunwar Shailubhai, PhD
This panel will explore:
• How AI is reshaping clinical trial design and execution
• The rise of AI-native clinical development platforms
• Cross-border collaboration opportunities between Japan and the U.S.
• The future of AI-enabled drug development ecosystems
7:15 - 8:30pm: Asian Cuisine Dinner and Networking
An intimate networking dinner designed to foster strategic partnerships, collaboration
opportunities, and high-level conversations among global industry leaders.
Location: Center City of Philadelphia, PA, USA
Attendance is limited and expected to fill quickly during DIA week.
Register now to secure your invitation to one of DIA 2026’s most anticipated executive
networking events.